Johnson & JohnsonJNJ:NYSE RT Quote|Last NASDAQ LS, VOL From CTA|USD After Hours:Last |01/31/25 EST 152.06-0.09(-0.06%) Volume 1,409,827 Close 152.15-0.72(-0.47%) Volume 7,036,913 52 week range 140.68-168.85 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...
Johnson & Johnson (JNJ.NYSE): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Johnson & Johnson | Nyse: JNJ | Nyse
JNJ US4781601046 Pharmaceuticals Market Closed -Nyse 04:00:02 2025-01-27 pm EST5-day change1st Jan Change 152.89USD+4.13%+3.99%+5.72% Jan. 27Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight RatingMT ...
01/27MicroStrategy is still loading up on bitcoin, but the pace of buying is slowing 01/27Barron'sDeepSeek Deep Sixes the Stock Market. How Far the S&P 500 Could Fall. Home Investing Quotes Stocks United States JNJ Overview Stock Screener ...
Johnson & Johnson (JNJ) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
JNJ:CA Analysis Johnson & Johnson: Q4 Earnings May Not Prompt Sustained Directional MovesThe Alpha SieveYesterday, 11:29 AM What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular TherapiesONeil TraderMon, Jan. 139 Comments Dividend Roundup: Why I Prefer Johnson & Johnson Over ...
JNJ-3.2 US Europe Asia FX Rates Futures Crypto RangeDropdown Markets Asia Dow4,144.4817.630.43% Nikkei 22539,646.25618.271.58% Hang Seng19,778.77-327.78-1.63% Shanghai3,213.62-29.00-0.89% Sensex76,404.99566.630.75% Singapore3,781.21-14.16-0.37% ...
Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States. The company offers a line of products for construction, maintenance, repair, remodeling, and decorating. It also provides home improvement products, such as appliances, seasonal and...
jnj.de johnson & johnson 138.14 -3.14% msf.de microsoft corporation 425.70 +3.48% xom.mx exxon mobil corporation 2,271.00 -1.76% exxo34.sa exxon mobil corporation 81.24 -3.68% prg.de the procter & gamble company 159.78 +2.66% mdo.de mcdonald's corporation 271.85...
It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Its other pipeline products ...